.;EFFECT: obtained a new compound 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5(10),8(9)-tetraen-17a-one, which can be used as an anti-oncological agent.;1 cl, 2 ex"/>
USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM
首页>
外国专利>
USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM
USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM
FIELD: chemistry.;SUBSTANCE: invention relates to the use of 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5(10),8(9)-tetraen-17a-one as an anti-oncological agent in mono- and adjuvant therapy for breast cancer, including triple negative form. ; .;EFFECT: obtained a new compound 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5(10),8(9)-tetraen-17a-one, which can be used as an anti-oncological agent.;1 cl, 2 ex
展开▼
机译：发明领域：本发明涉及3-O-氨磺酰氧基-7β-甲基-D-homo-6-oxaestra-1,3,5（10），8（9）-tetraen-17a-one的用途在乳腺癌的单药和辅助疗法中作为抗肿瘤药，包括三联阴性形式。 ; 。;效果：获得了新的化合物3-O-氨磺酰氧基-7β-甲基-D -homo-6-oxaestra-1,3,5（10），8（9）-tetraen-17a-one，可用作抗肿瘤药。; 1 cl，2 ex
展开▼
